<?xml version="1.0" encoding="UTF-8"?>
<p>The economic analysis was carried out from the perspective of the SUS. The perspective of the public health system included direct medical costs (medical consultation, medication, laboratory tests, and hospitalizations due to complications). The costs were estimated in reais, with reference to the year 2018 (US$ = 1.00 - R$ 3.89). Future costs and effectiveness were discounted at 5% 
 <italic>per</italic> year.
</p>
